PharmaTimes Dr Soriot concluded by saying that "combined with our on-market portfolio, including Symbicort ( budesonide /formoterol), and our strong pipeline, the agreem...
Seeking Alpha The company's current commercial efforts are focused on five products: UCERIS™ (budesonide) extended release tablets for the induction of remission in patients with active, mild to moderate ulcerative colitis and ZEGERID® ( omeprazole /sodium ...
Atlantic Information Services, Inc. ... other products such as Advair [Glaxo's combination therapy (salmeterol/fluticasone propionate) approved for COPD and asthma] and Symbicort [( budesonide /formoterol fumarate dihydrate), an AstraZeneca drug also approved for both COPD and asthma] ...
Medscape They identified 18,266 patients who had received an initial prescription for metformin or a sulfonylurea from 2001 to 2008. The current study cohort consisted of 1077 (5.9%) of these patients with diabetes who also had COPD, defined as receiving 2 ...
Quotidiano Sanità Lo studio PATHOS, pubblicato su British Medical Journal, dimostra come la combinazione sia associata ad una minore incidenza di polmonite e decessi correlati, rispetto alla terapia a base di fluticasone salmeterolo. Entrambe le terapie combinate sono ... and more »
Pulse Admissions to hospital because of pneumonia were 74% higher in the fluticasone/salmeterol group (7.4 per 100 patient years), compared with the budesonide /formeterol group (4.3 per 100 patient years). The pneumonia rate was 73% higher in those taking ...
